Monday, 21 May 2012

Breast Cancer Vaccine-Recurrence Rates-Immune Response-Clinical Trial

Hybrid Vaccine Demonstrates Potential To Prevent Breast Cancer Recurrence

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center... read more..

1 comment:

  1. This method is without a doubt aesthetically certainly appropriate choice. Every one in concerns most important ones can be created by a lot of historical techniques. I can recommend animoto quite a bit. Health Line